Michael John Kazley - 16 Oct 2025 Form 4 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Oct 2025, 21:40:20 UTC
Next SEC filing
19 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Kazley

Key filing fact

Michael John Kazley filed Form 4 for NovaBay Pharmaceuticals, Inc. (NBY) on 20 Oct 2025.

Key facts

  • This page summarizes Michael John Kazley's Form 4 filing for NovaBay Pharmaceuticals, Inc. (NBY).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 20 Oct 2025, 21:40.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002091727 Primary reporting owner

Kazley Michael John

Relationship
Chief Executive Officer, Director, 10%+ Owner
Address
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Signature
/s/ Michael Kazley
Signature date
20 Oct 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NBY transaction Derivative

Series D Non-Voting Convertible Preferred Stock

Award

Transaction value
$0
Shares
+220,663
Change %
Price
$0.000000
Shares after
220,663
Date
16 Oct 2025
Ownership
By R01 Entities
Underlying class
Common Stock
Underlying amount
35,306,080
Exercise price
$0.000000
Footnotes
F1, F2, F3
NBY transaction Derivative

Series E Non-Voting Convertible Preferred Stock

Award

Transaction value
$0
Shares
+134,375
Change %
Price
$0.000000
Shares after
134,375
Date
16 Oct 2025
Ownership
By R01 Entities
Underlying class
Common Stock
Underlying amount
21,500,000
Exercise price
$0.000000
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On October 9, 2025, R01 Fund LP ("R01 LP"), David Lazar (the "Seller") and certain other investors entered into a securities purchase agreement pursuant to which R01 LP purchased all of Seller's rights, title and interest in (i) 220,663 shares of the Issuer's Series D Non-Voting Convertible Preferred Stock, par value $0.01 per share (the "Series D Preferred Stock") and (ii) the rights and obligation to purchase 134,375 shares of the Issuer's Series E Non-Voting Convertible Preferred Stock, par value $0.01 per share (the "Series E Preferred Stock").

Footnote F2

Following stockholder approvals of proposals 5 and 9 set forth in the Issuer's Definitive Proxy Statement on Schedule 14A, filed by the Issuer with the Securities and Exchange Commission on September 23, 2025, at the Issuer's annual meeting on October 16, 2025 (the "Meeting"), (i) each share of Series D Convertible Preferred Stock will automatically convert into 160 shares of common stock at the option of the holder or within three business days of the Meeting, and (ii) the Issuer issued the Series E Preferred Stock, each share of which will automatically convert into 160 shares of common stock at the option of the holder or within thirty business days of the Meeting.

Footnote F3

The reported securities may also be deemed to be beneficially owned by R01 Capital LLC ("R01 Capital"), R01 Capital Manager LLC ("R01 Capital Manager") and Michael Kazley ("Mr. Kazley" and together with R01 Capital, R01 Capital Manager and R01 LP, the "R01 Entities"), each of which or whom disclaim beneficial ownership of these shares, except to the extent of its or his pecuniary interest in such shares, if any. R01 Capital is the general partner of R01 LP. R01 Capital Manager is the investment manager for R01 Capital. Mr. Kazley is the managing member of R01 Capital Manager.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .